Expression of FOXM1 and Aurora-A predicts prognosis and sorafenib efficacy in patients with hepatocellular carcinoma

BACKGROUND: Effective prognostic biomarkers and powerful target-therapeutic drugs are needed for improving the treatment of Hepatocellular carcinoma (HCC). OBJECTIVE: This study aimed to evaluate the expression of FOXM1 and Aurora-A and their prognostic value in HCC. METHODS: We determined the diffe...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Wen-Lung, Chuang, Shih-Chang, Wang, Yu-Chu, Chen, Lin-An, Huang, Jian-Wei, Chang, Wen-Tsan, Wang, Shen-Nien, Lee, King-Teh, Lin, Chang-Shen, Kuo, Kung-Kai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7458516/
https://www.ncbi.nlm.nih.gov/pubmed/32390596
http://dx.doi.org/10.3233/CBM-190507

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7458516/
https://www.ncbi.nlm.nih.gov/pubmed/32390596
http://dx.doi.org/10.3233/CBM-190507

Ejemplares similares